AKR1D1 and type 2 diabetes mellitus: Consistent with the previous data, in obese female patients, AKR1D1 expression was significantly lower in advanced fibrosis (F0–1: 0.85 ± 0.06 vs. F3–4: 0.59 ± 0.09, p = 0.05) and in patients with T2DM (Normal: 0.90 ± 0.07 vs. T2DM: 0.60 ± 0.06, p < 0.01).